Chronic pulmonary Aspergillosis in a patient with poorly controlled diabetes: A case report and literatures review
Abstract Chronic pulmonary aspergillosis (CPA) often manifests in patients with a history of pulmonary tuberculosis and is typically characterized by recurrent hemoptysis, weight loss, and frequently coexists with poorly controlled diabetes. While weight gain is acknowledged as a valuable clinical marker for monitoring therapeutic responses in CPA, there is a scarcity of case reports exploring this aspect. Furthermore, the impact of stringent blood sugar management in diminishing CPA activity and preventing the recurrence of hemoptysis is also underreported. In this context, we present the case of a 64‐year‐old male who experienced massive hemoptysis. He had a background of uncontrolled diabetes and a history of fully treated pulmonary tuberculosis. Following therapeutic embolization, he was diagnosed with CPA that had transformed into invasive pulmonary aspergillosis (IPA) and underwent antifungal therapy for 9 months. Notably, we observed an inverse correlation between the patient's improved blood sugar control and weight gain with the serum IgG levels for Aspergillosis. This case highlights the potential benefits of non‐invasive monitoring of CPA activity and the identification of treatment responders through effective blood sugar management and weight gain..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Respirology Case Reports - 12(2024), 1, Seite n/a-n/a |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tzu‐I Chuang [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Chronic pulmonary aspergillosis |
|---|
| doi: |
10.1002/rcr2.1283 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ096405023 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ096405023 | ||
| 003 | DE-627 | ||
| 005 | 20240413151124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/rcr2.1283 |2 doi | |
| 035 | |a (DE-627)DOAJ096405023 | ||
| 035 | |a (DE-599)DOAJa86aec313b8245dc91b0e9304e335d4f | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC705-779 | |
| 100 | 0 | |a Tzu‐I Chuang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chronic pulmonary Aspergillosis in a patient with poorly controlled diabetes: A case report and literatures review |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Chronic pulmonary aspergillosis (CPA) often manifests in patients with a history of pulmonary tuberculosis and is typically characterized by recurrent hemoptysis, weight loss, and frequently coexists with poorly controlled diabetes. While weight gain is acknowledged as a valuable clinical marker for monitoring therapeutic responses in CPA, there is a scarcity of case reports exploring this aspect. Furthermore, the impact of stringent blood sugar management in diminishing CPA activity and preventing the recurrence of hemoptysis is also underreported. In this context, we present the case of a 64‐year‐old male who experienced massive hemoptysis. He had a background of uncontrolled diabetes and a history of fully treated pulmonary tuberculosis. Following therapeutic embolization, he was diagnosed with CPA that had transformed into invasive pulmonary aspergillosis (IPA) and underwent antifungal therapy for 9 months. Notably, we observed an inverse correlation between the patient's improved blood sugar control and weight gain with the serum IgG levels for Aspergillosis. This case highlights the potential benefits of non‐invasive monitoring of CPA activity and the identification of treatment responders through effective blood sugar management and weight gain. | ||
| 650 | 4 | |a chronic pulmonary aspergillosis | |
| 650 | 4 | |a diabetes mellitus | |
| 653 | 0 | |a Diseases of the respiratory system | |
| 700 | 0 | |a Pin‐Kuei Fu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Respirology Case Reports |d Wiley, 2015 |g 12(2024), 1, Seite n/a-n/a |w (DE-627)DOAJ000057134 |x 20513380 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g number:1 |g pages:n/a-n/a |
| 856 | 4 | 0 | |u https://doi.org/10.1002/rcr2.1283 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a86aec313b8245dc91b0e9304e335d4f |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1002/rcr2.1283 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2051-3380 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2024 |e 1 |h n/a-n/a | ||